Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium lactate + sodium chloride + calcium chloride + magnesium chloride + dextrose
- Development stage
- Approved
- Lead developer
- Baxter Healthcare Corporation
- Modality
- Small Molecules
- Administration
- Intraperitoneal
01
Overview
Sodium lactate + sodium chloride + calcium chloride + magnesium chloride + dextrose is a **peritoneal dialysis solution** used intraperitoneally for the management of acute renal failure, chronic renal failure, and chronic kidney failure in patients undergoing continuous ambulatory peritoneal dialysis or automated peritoneal dialysis. Marketed as **DIANEAL** and related formulations, it was originally developed by Baxter Healthcare and is now associated with Vantive and Fresenius Medical Care in U.S. product lineage context. The solution is a **small-molecule electrolyte and carbohydrate formulation** in which dextrose creates an osmotic gradient that promotes ultrafiltration across the peritoneal membrane, while the electrolyte composition helps support fluid and solute exchange during dialysis.
- Brand names
- DIANEALDIANEAL PD-2DIANEAL LOW CALCIUM WITH DEXTROSE
- Other names
- sodium lactate + sodium chloride + calcium chloride + magnesium chloride + dextroseperitoneal dialysis solution
Beyond the preview
Go deeper on sodium lactate + sodium chloride + calcium chloride + magnesium chloride + dextrose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium lactate + sodium chloride + calcium chloride + magnesium chloride + dextrose.